<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Serum interleukin-2 receptor levels were evaluated in 69 patients who had <z:hpo ids='HP_0011010'>chronic</z:hpo> bilateral <z:hpo ids='HP_0000554'>uveitis</z:hpo> and in 22 control subjects </plain></SENT>
<SENT sid="1" pm="."><plain>Fifty-one of the 69 patients with <z:hpo ids='HP_0000554'>uveitis</z:hpo> had the ocular type of <z:chebi fb="6" ids="22696">Beh</z:chebi>��et's disease and 18 had <z:e sem="disease" ids="C0030593" disease_type="Disease or Syndrome" abbrv="">pars planitis</z:e> (<z:hpo ids='HP_0012124'>intermediate uveitis</z:hpo>) </plain></SENT>
<SENT sid="2" pm="."><plain>The mean serum interleukin-2 receptor level was 412.6 +/- 94.6 U/ml for the control group, 465.0 +/- 96.6 U/ml for the patients with <z:hpo ids='HP_0012124'>intermediate uveitis</z:hpo>, and 810.9 +/- 369.3 U/ml for those with ocular <z:chebi fb="6" ids="22696">Beh</z:chebi>çet's disease </plain></SENT>
<SENT sid="3" pm="."><plain>The serum interleukin-2 receptor levels of patients with ocular <z:chebi fb="6" ids="22696">Beh</z:chebi>çet's disease were significantly different from the levels of both the control and the <z:hpo ids='HP_0012124'>intermediate uveitis</z:hpo> groups (P &lt; .001) </plain></SENT>
<SENT sid="4" pm="."><plain>The differences in serum levels of patients with <z:hpo ids='HP_0012124'>intermediate uveitis</z:hpo> and the levels of the control subjects were not statistically significant </plain></SENT>
<SENT sid="5" pm="."><plain>Treatment of patients with ocular <z:chebi fb="6" ids="22696">Beh</z:chebi>çet's disease for four to six weeks with either <z:chebi fb="0" ids="4031">cyclosporine</z:chebi>, <z:chebi fb="0" ids="6888">methylprednisolone</z:chebi>, or a combination of both, decreased the intraocular <z:mp ids='MP_0001845'>inflammation</z:mp> in nearly <z:hpo ids='HP_0000001'>all</z:hpo> cases </plain></SENT>
<SENT sid="6" pm="."><plain>The influence of treatment on the level of serum interleukin-2 receptor, however, was variable </plain></SENT>
</text></document>